​

Funding Round

Series B - Eden Biologics

Series B - Eden Biologics

Investment Firm

Overview

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Announced Date

Jun 19, 2014

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Milestone Capital China

Milestone Capital China

Milestone Capital China is a early_stage_venture and late_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorMilestone Capital China
Participant InvestorChina Development Industrial Bank (CDIB)
Participant InvestorAllen Chao
Participant InvestorBiomark Capital
Participant InvestorKleiner Perkins

Round Details and Background

Eden Biologics raised $35000000 on 2014-06-19 in Series B

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 02, 2018
Post-IPO Equity - Eden Biologics
1-undefined
Dec 17, 2012
Series A - Eden Biologics
1-undefined
May 11, 2015
Series C - Eden Biologics
3-45.6M
Jun 19, 2014
Series B - Eden Biologics
5-35.0M

Recent Activity

There is no recent news or activity for this profile.